Sunitinib for the treatment of gastrointestinal stromal tumours

Gastrointestinal stromal tumours - sunitinib: review decision - January 2012 information

Appendix A: decision paper presented to the Institute's Guidance Executive (PDF 74 KB)

Gastrointestinal stromal tumours - sunitinib: review update - November 2011 information

Appendix A: provisional matrix of stakeholders (PDF 55 KB)

Appendix B: proposal paper presented to the Institute's Guidance Executive (PDF 101 KB)

Gastrointestinal stromal tumours - sunitinib: final appraisal determination information

Gastrointestinal stromal tumours - sunitinib: final appraisal determination (PDF 99 KB)

Response to consultee, commentator and public comments on the ACD and comments from website consultation (PDF 272 KB)

Consultee and commentator comments on the ACD

Sarcoma UK, Rarer Cancers Forum and GIST Support UK joint submission (PDF 91 KB)

Royal College of Nursing (PDF 18 KB)

Pfizer (PDF 258 KB)

Peninsula Technology Assessment Group (PDF 90 KB)

Department of Health (PDF 19 KB)

Professor Ian Judson (PDF 32 KB)

Gastrointestinal stromal tumours - sunitinib: appraisal consultation

Gastrointestinal stromal tumours - sunitinib: appraisal consultation document information

Gastrointestinal stromal tumours - sunitinib: evaluation report

Pre-meeting briefing (PDF 115 KB)

Evidence Review Group report (PDF 719 KB)

Evidence Review Group additional notes for the ACD meeting (PDF 23 KB)

Non-manufacturer submissions

Association of Upper GI Surgeons of GB and NI (PDF 18 KB)

Plymouth PCT (PDF 34 KB)

Royal College of Physicians (PDF 50 KB)

Royal College of Nursing (PDF 27 KB)

Sarcoma UK/GIST Support UK (PDF 49 KB)

Pfizer (PDF 904 KB)

Expert written personal statements

Pendleton (PDF 33 KB)

Novelli (PDF 37 KB)

GIST - sunitinib: final scope (PDF 28 KB)

GIST - sunitinib: response to consultee and commentator comments on the draft scope (PDF 99 KB)

GIST - sunitinib: response to consultee and commentator comments on the provisional matrix (PDF 21 KB)